Transforming cancer care for all

ACT Genomics is an internationally-recognized award-winning cancer solution provider. Combining our expertise in the fields of cancer genomics and bioinformatics with our cutting-edge technologies, we are able to assist medical practitioners and scientists with genomics-driven recommendations and data for cancer treatment strategy and discovery.

Turning Genomics
Into Action

ACT Genomics is a leading genomics diagnostics and research company specializing in precision medicine for cancer patients. Our technology empower clinicians and patients to make informed decisions about cancer treatment options.

ACT Genomics is a world-leading molecular insights company that is making precision medicine a reality for thousands.

Treatment Selection
Disease Monitoring
Risk Prediction

About ACT Genomics

Comprehensive genomic profiling for personalised cancer treatment
Actionable Cancer Solutions
The First Asia-Based Company to Receive FDA Clearance

Transforming cancer care for all